Abraxane Prices, Coupons and Patient Assistance Programs
Abraxane (paclitaxel protein-bound) is a member of the mitotic inhibitors drug class and is commonly used for Breast Cancer, Breast Cancer - Metastatic, Non-Small Cell Lung Cancer and others.
Abraxane Prices
The cost for Abraxane intravenous powder for injection 100 mg is around $1,588 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
This Abraxane price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
Intravenous Powder For Injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $1,588.05 | $1,588.05 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardPlease note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Abraxane Coupons and Rebates
Abraxane offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.
Abraxane Celgene Co-Pay Program: Eligible commercially insured patients may pay $0 per prescription with savings of up to $10,000 per calendar year; for additional information contact the program at 800-931-8691 ext 4102.
| Applies to: | Abraxane |
| Number of uses: | per prescription per calendar year |
Patient Assistance Programs for Abraxane
Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.
Provider: Celgene Patient Support
Elligibility requirements:- Determined case by case
- At or below 650% of FPL
- Any diagnosis deemed medically necessary by the patient's oncologist
- The patient must also be a US resident with a prescription from a US doctor.
- This program also provides copay assistance.
Applicable drugs:
- Abraxane (paclitaxel protein-bound particles) Injectable Suspension; IV
Provider: HealthWell Foundation Copay Program
Elligibility requirements:- May have insurance
- Varies
- FDA Approved Diagnosis - See Program Website for Details
- The patient must also be residing in the US.
- This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.
Applicable drugs:
- Abraxane (paclitaxel protein-bound particles) Injectable Suspension; IV
Provider: Patient Access Network Foundation (PAN)
Elligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
- Abraxane (paclitaxel protein-bound particles) Injectable Suspension; IV
Provider: Bristol Myers Squibb (BMS) Patient Support Program (Expanded: COVID-19)
Elligibility requirements:- Determined case by case
- Not disclosed
- FDA-approved diagnosis
- The patient must also be residing in the US.
- Eligibility determined on a case-by-case basis. Contact program for details: 1-800-721-8909
Applicable drugs:
- Abraxane (paclitaxel protein-bound particles) Injectable Suspension; IV
More about Abraxane (paclitaxel protein-bound)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- En Español
- 6 Reviews
- Drug class: mitotic inhibitors
- FDA Approval History
